Craft

Zomedica Pharmaceuticals

Stock Price

$0.1

2024-10-29

Market Capitalization

$121 M

2024-10-29

Revenue

$32 M

FY, 2025

Zomedica Pharmaceuticals Summary

Company Summary

Overview
Zomedica Pharmaceuticals is a veterinary pharmaceutical company targeting health and wellness solutions for companion animals (canine, feline and equine). Its portfolio of products includes veterinary-approved drugs combined with delivery systems, as well as devices, diagnostics and other solutions deemed appropriate for veterinary use.
Type
Public
Status
Active
Founded
2015
HQ
Ann Arbor, MI, US | view all locations
Website
http://www.zomedica.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Jeff Rowe

    Jeff Rowe, Chairman

    • Johnny D. Powers, Director

      • Larry Heaton

        Larry Heaton, Chief Executive Officer

      • Ann Cotter

        Ann Cotter, Chief Financial Officer

      LocationsView all

      2 locations detected

      • Ann Arbor, MI HQ

        United States

        3928 Varsity Dr

      • Ann Arbor, MI

        United States

        3928 Varsity Dr

      Zomedica Pharmaceuticals Financials

      Summary Financials

      Revenue (Q1, 2026)
      $8.8M
      Gross profit (Q1, 2026)
      $5.5M
      Net income (Q1, 2026)
      ($4.5M)
      Cash (Q1, 2026)
      $9.4M
      EBIT (Q1, 2026)
      ($4.9M)
      Enterprise value
      $113.6M

      Footer menu